Find what you are looking for
Need help?
Questions?
We will be glad to help you
Neuroalivio
- Description
- Behavioral disorder modifier.
- For dogs.
- Palatable tablets.
- Formula
Each tablet contains:
Buspirone ……………………………………….40 mg
Excipients q.s. …………………………….. 2000 mg- Indications
Neuroalivio is a behavior modifier for animals’ abnormal conduct caused by mild or severe anxiety such as:
- Separation anxiety disorder evidenced by damages such as: damages caused during the owners’ absence, excessive barking and wailing, bowel movement and urine incontinence in inappropriate places, except for the normal marking of males.
- Compulsive behavior evidenced by: tail chasing, acral lick granuloma, flank licking.
- Dominance aggression or fearful aggression evidenced by: threatening growling when receiving orders, lack of obedience.
- Adaptation issues towards new situations such as: the presence of a new member in the house (baby, new animals); temporary or definitive absence of a family member; adjustment to changes of environment.
- Slightly fearful behavior evidenced by: refusal to leave the house; difficulties in walking during strolls.
- Neuroalivio also eases the correctional learning of behavioral disorders.
Important notice: In order to achieve maximum therapeutic effect of Neuroalivio, the treatment should be given with the corrective therapy for the underlying pathology.
- Package
Container with 30 palatable tablets.
Registered in
- Argentina
- Brazil
- Ecuador
- Paraguay
- Peru
- Uruguay